<PAGE>


===============================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                                    Form 10-Q

(Mark One)

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934 For the quarterly period ended March 31, 2002

                                       OR

[_]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934 For the transition period from ________ to ________.

                       Commission file number - 333-56097

                            ------------------------

                          HUDSON RESPIRATORY CARE INC.
             (Exact name of registrant as specified in its charter)

                            ------------------------

                 California                                 95-1867330
     (State or other jurisdiction of                    (I.R.S. Employer
       incorporation or organization)                  Identification No.)


       27711 Diaz Road, P.O. Box 9020                         92589
            Temecula, California                            (Zip Code)
  (Address of Principal Executive Offices)

                                 (909) 676-5611
              (Registrant's telephone number, including area code)

                                 Not Applicable
              (Former name, former address and former fiscal year,
                         if changed since last report).

     Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes [_] No [X]

     The number of shares of Common Stock, $0.01 par value, outstanding (the
only class of common stock of the Company outstanding) was 10,654,293 on June
28, 2002.

================================================================================

<PAGE>


                  HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES

                          QUARTER ENDED MARCH 31, 2002

                                TABLE OF CONTENTS


<TABLE>
<CAPTION>
                                                                                                          Page
PART  I      FINANCIAL INFORMATION                                                                        ----
<S>          <C>                                                                                          <C>
             Item 1.  Unaudited Condensed Consolidated Financial Statements:

                      Unaudited Condensed Consolidated Balance Sheets as of March 31, 2002 and
                      December 31, 2001 ................................................................     1

                      Unaudited Condensed Consolidated Statements of Operations for the Three Months
                      Ended March 31, 2002 and March 31, 2001 ..........................................     3

                      Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months
                      Ended March 31, 2002 and March 31, 2001 ..........................................     4

                      Notes to Unaudited Condensed Consolidated Financial Statements ...................     5

             Item 2.  Management's Discussion and Analysis of Financial Condition and
                      Results of Operations ............................................................    11

             Item 3.  Quantitative and Qualitative Disclosures About Market Risks ......................    18

PART II. OTHER INFORMATION

             Item 1.  Legal Proceedings ................................................................    19

             Item 2.  Changes in Securities ............................................................    19

             Item 3.  Defaults Upon Senior Securities ..................................................    19

             Item 4.  Submission of Matters to a Vote of Security Holders ..............................    19

             Item 5.  Other Information ................................................................    19

             Item 6.  Exhibits and Reports on Form 8-K .................................................    19

SIGNATURE ..............................................................................................    20
</TABLE>


                                       i

<PAGE>


                  HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES
              (A majority-owned subsidiary of River Holding Corp.)

                 UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

                                     ASSETS

                             (amounts in thousands)

<TABLE>
<CAPTION>
                                                                               March 31,       December 31,
                                                                                 2002              2001
                                                                              -----------      ------------
<S>                                                                           <C>               <C>
CURRENT ASSETS:
     Cash .................................................................   $     6,230       $     7,085
     Accounts receivable, less allowance for doubtful accounts of $1,951
       and $1,801 at March 31, 2002 and December 31, 2001, respectively ...        21,399            19,287
     Inventories ..........................................................        23,757            25,218
     Other current assets .................................................         1,970             1,483
                                                                              -----------       -----------
     Total current assets .................................................        53,356            53,073

   PROPERTY, PLANT AND EQUIPMENT, net .....................................        45,183            46,268

   OTHER ASSETS:
     Goodwill, net ........................................................        29,141            28,498
     Deferred financing costs, net ........................................         7,880             8,316
     Other assets .........................................................         1,026               900
                                                                              -----------       -----------
     Total other assets ...................................................        38,047            37,714


       Total assets .......................................................   $   136,586       $   137,055
                                                                              ===========       ===========
</TABLE>

            See notes to unaudited consolidated financial statements.


                                       1

<PAGE>

                  HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES
              (A majority-owned subsidiary of River Holding Corp.)

                 UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

               LIABILITIES, MANDATORILY-REDEEMABLE PREFERRED STOCK
                            AND STOCKHOLDERS' DEFICIT

                (amounts in thousands, except per share amounts)
<TABLE>
<CAPTION>

                                                                               March 31,       December 31,
                                                                                 2002             2001
                                                                              -----------      ------------
<S>                                                                           <C>              <C>
CURRENT LIABILITIES:
 Notes payable to bank ................................................     $    21,306       $    20,680
 Accounts payable .....................................................          11,149            15,251
 Accrued liabilities ..................................................          21,068            17,302
                                                                            -----------       -----------
 Total current liabilities ............................................          53,523            53,233

NOTE PAYABLE TO AFFILIATE, net of current portion .....................          17,217            17,217

SENIOR SUBORDINATED NOTES PAYABLE .....................................         115,000           115,000

NOTES PAYABLE TO BANK, net of current portion .........................          71,450            73,250

OTHER NON-CURRENT LIABILITIES .........................................           1,370             1,187
                                                                            -----------       -----------

   Total liabilities ..................................................         258,560           259,887

 MANDATORILY-REDEEMABLE PREFERRED STOCK, $0.01 par value:
     authorized--1,800 shares; issued and outstanding-445 shares;
     liquidation preference:  $44,474 .................................          43,880            43,847
 Accrued preferred stock dividend, payable in kind ....................           2,421             1,142
                                                                            -----------       -----------
                                                                                 46,301            44,989

STOCKHOLDERS' EQUITY (DEFICIT):
 Common stock, $0.01 par value:
 Authorized--15,000 shares, issued and outstanding--10,654 ............          98,258            98,258
 Junior preferred stock, $0.01 par value; 6 shares authorized; 3 shares
     outstanding ......................................................           3,228             3,137
 Cumulative translation adjustment ....................................            (285)             (698)
 Accumulated deficit ..................................................        (269,476)         (268,518)
                                                                            -----------       -----------
   Total stockholders' deficit ........................................        (168,275)         (167,821)
                                                                            -----------       -----------


           Total liabilities, mandatorily-redeemable preferred stock
              and stockholders' deficit ...............................     $   136,586       $   137,055
                                                                            ===========       ===========
</TABLE>

            See notes to unaudited consolidated financial statements





                                       2

<PAGE>

                  HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES
              (A majority-owned subsidiary of River Holding Corp.)

            UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                             (amounts in thousands)

<TABLE>
<CAPTION>

                                                                                  Three Months Ended
                                                                              -----------------------------
                                                                               March 31,         March 31,
                                                                                 2002              2001
                                                                              -----------       -----------
<S>                                                                           <C>               <C>
NET SALES                                                                     $    42,985       $    37,805
COST OF SALES ...........................................................          24,925            28,030
                                                                              -----------       -----------
    Gross Profit ........................................................          18,060             9,775
OPERATING EXPENSES:
   Selling, distribution, general & administrative ......................          11,822            12,521
   Amortization of goodwill .............................................              --             1,966
   Research and development .............................................             597               464
                                                                              -----------       -----------
                                                                                   12,419            14,951
                                                                              -----------       -----------
      Income (loss) from operations .....................................           5,641            (5,176)
                                                                              -----------       -----------

INTEREST EXPENSE AND OTHER ..............................................           4,863             7,499
                                                                              -----------       -----------

      Net income (loss)  before benefit for income taxes ................             778           (12,675)
                                                                              -----------       -----------

PROVISION FOR INCOME TAXES ..............................................             424               188
                                                                              -----------       -----------


      Net Income (loss) .................................................     $       354       $   (12,863)
                                                                              ===========       ===========
OTHER COMPREHENSIVE INCOME:
    Foreign currency translation gain (loss) ............................             413               728
                                                                              -----------       -----------


      Comprehensive income (loss) .......................................     $       767       $   (12,135)
                                                                              ===========       ===========
</TABLE>

            See notes to unaudited consolidated financial statements.


                                       3

<PAGE>

                  HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES
              (A majority-owned subsidiary of River Holding Corp.)

            UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                              (amount in thousands)

<TABLE>
<CAPTION>
                                                                                   Three Months Ended
                                                                              -----------------------------
                                                                               March 31,         March 31,
                                                                                 2002              2001
                                                                              -----------       -----------
<S>                                                                           <C>               <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss) .....................................................       $       354       $   (12,863)
Adjustments to reconcile net income to net cash provided by (used in)
   operating activities--
     Depreciation and amortization ....................................             2,389             4,043
     Amortization of deferred financing costs .........................               436               235
     Provision for bad debts ..........................................               150                --
     Loss on disposal of equipment ....................................               632                --
Change in operating assets and liabilities:

     Accounts receivable ..............................................            (2,139)              936
     Inventories ......................................................             1,599             8,088
     Other current assets .............................................              (263)           (1,300)
     Other assets .....................................................              (192)           (2,307)
     Accounts payable .................................................            (4,137)           (6,049)
     Accrued liabilities ..............................................             2,914             5,381
     Other non-current liabilities ....................................               819             1,009
                                                                              -----------       -----------
        Net cash provided by (used in) operating activities ...........             2,562            (2,827)

CASH FLOWS FROM INVESTING ACTIVITIES:
   Purchases of property, plant and equipment .........................            (1,911)           (1,139)
   Retirements of intangible assets ...................................                --             1,957
                                                                              -----------       -----------
        Net cash (used in) provided by investing activities ...........            (1,911)              818

CASH FLOWS FROM FINANCING ACTIVITIES:
   Repayment of notes payable to bank .................................            (1,546)           (1,500)
   Proceeds from bank borrowings ......................................                --             7,736
   Additions of deferred financing costs ..............................                --               106
                                                                              -----------       -----------
        Net cash (used in) provided by financing activities ...........            (1,546)            6,342

Effect of exchange rate changes on cash ...............................                40               729
                                                                              -----------       -----------

NET (DECREASE) INCREASE IN CASH .......................................              (855)            5,062
                                                                              -----------       -----------

CASH, beginning of period .............................................             7,085             3,530
                                                                              -----------       -----------

CASH, end of period ...................................................       $     6,230       $     8,592
                                                                              ===========       ===========

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
   Cash paid during the period for:

      Interest ........................................................       $     1,542       $     2,282
                                                                              ===========       ===========

      Income taxes ....................................................       $     1,580       $        28
                                                                              ===========       ===========
NON-CASH FINANCING ACTIVITIES:

   Preferred dividends accrued or paid-in-kind ........................       $     1,267       $     1,163
                                                                              ===========       ===========
</TABLE>

            See notes to unaudited consolidated financial statements.


                                       4

<PAGE>

                  HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES
              (A majority-owned subsidiary of River Holding Corp.)

         NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

                                 MARCH 31, 2002

1.   Financial Statements. The condensed consolidated financial statements
included herein have been prepared by the Company, without audit, and include
all adjustments which are, in the opinion of management, necessary for a fair
presentation of the financial position at March 31, 2002, and the results of
operations and cash flows for the three-month periods ended March 31,2002 and
March 31, 2001 pursuant to the rules and regulations of the Securities and
Exchange Commission ("SEC"). All such adjustments are of a normal recurring
nature. Certain information and footnote disclosures normally included in
financial statements prepared in accordance with generally accepted accounting
principles have been condensed or omitted pursuant to such rules and
regulations. Although the Company believes that the disclosures in such
financial statements are adequate to make the information presented not
misleading, the accompanying unaudited condensed, consolidated financial
statements should be read in conjunction with the Company's 2001 audited
financial statements and the notes thereto included in its Form 10-K filed with
the SEC. The results of operations for the three-month period ended March 31,
2002 are not necessarily indicative of the results to be achieved for a full
year.

     Recent Accounting Pronouncements

     Effective January 1, 2001, the Company adopted Statement of Financial
Accounting Standards ("SFAS") No.133, "Accounting for Derivative Instruments and
Hedging Activities," as amended by SFAS No. 137 and SFAS No. 138. SFAS No. 133,
as amended, establishes accounting and reporting standards for derivative
instruments. The statement requires that every derivative instrument be recorded
in the balance sheet as either an asset or liability measured at its fair value,
and that changes in the derivative's fair value be recognized currently in
earnings unless specific hedge accounting criteria are met. The adoption of this
new standard did not have a material impact on the Company's financial
statements.

     In June 2001, the Financial Accounting Standards Board ("FASB") issued
Statement of Financial Accounting Standards No. 141, "Business Combinations".
This Statement addresses financial accounting and reporting for business
combinations and supersedes APB Opinion No. 16, "Business Combinations," and
FASB Statement No. 38, "Accounting for Preacquisition Contingencies of Purchased
Enterprises." All business combinations in the scope of this Statement are to be
accounted for using one method, the purchase method. Any acquisitions made by
the Company after June 2001 will be recorded in accordance with SFAS 141.

     Also in June 2001, the FASB issued Statement of Financial Accounting
Standards No. 142, "Goodwill and Other Intangible Assets" ("SFAS 142"). SFAS 142
addresses financial accounting and reporting for acquired goodwill and other
intangible assets and supersedes APB Opinion No. 17, "Intangible Assets." This
pronouncement addresses, among other things, how goodwill and other intangible
assets should be accounted for after they have been initially recognized in the
financial statements. Goodwill is no longer to be amortized but is assessed at
least annually for impairment using a fair value methodology. The Company
stopped amortizing goodwill, effective January 1, 2002, and as a result an
equivalent charge for goodwill amortization will not be made in 2002. The
Company is still in the process of completing its transitional impairment test,
which is expected to be completed by the end of the second quarter of 2002. Pro
forma net loss for the three months ended March 31, 2001, excluding amortization
of $2.0 million for that period, would have been $10,135 compared to $12,135 as
reported. The slight change in goodwill from the three months ended March 31,
2002 stems from changes in foreign currency exchange rates.

     Also in June 2001, the FASB issued SFAS No. 143, "Accounting for Asset
Retirement Obligations" ("SFAS 143"). SFAS 143 addresses financial accounting
and reporting obligations associated with the retirement of tangible long-lived
assets and the associated asset retirement costs. It requires entities to record
the fair value of a liability for an asset retirement obligation in the period
in which it is incurred. When the liability is initially recorded, the entity
capitalizes a cost by increasing the carrying amount of the related long-lived
asset. Over time, the liability is acreted to


                                       5

<PAGE>

its present value each period, and the capitalized cost is depreciated over the
useful life of the related asset. Upon settlement of the liability, an entity
either settles the obligation for its recorded amount or incurs a gain or loss
upon settlement. SFAS 143 is effective January 1, 2003. The Company does not
expect the adoption of SFAS 143 to have a material impact on the Company's
financial statements.

     In August 2001, the FASB issued SFAS 144 "Accounting for the Impairment or
Disposal of Long-Lived Assets." This statement addresses financial accounting
and reporting for the impairment or disposal of long-lived assets. This
statement supercedes SFAS No. 121, "Accounting for the Impairment of Long-Lived
Assets and for Long-Lived Assets to be Disposed Of," and the accounting and
reporting provisions of APB Opinion No. 30, "Reporting the Results of Operations
- Reporting the Effects of a Disposal of a Segment of a Business and
Extraordinary, Unusual and Infrequently Occurring Events and Transactions," for
the disposal of a segment of a business (as previously defined in that Opinion).
SFAS No. 144 was effective January 1, 2002. The adoption of SFAS 144 did not
have a material impact on the Company's financial statements.

2.   Inventories. Inventories consisted of the following (amounts in thousands):

<TABLE>
<CAPTION>

                                                March 31,          December 31,
                                                  2002                 2001
                                              -------------        ------------
<S>                                           <C>                  <C>
Raw materials ...........................     $       6,275        $      7,377
Work-in-process .........................             6,424               5,392
Finished goods ..........................            13,212              14,481
                                              -------------        ------------
                                                     25,911              27,250
Provision for obsolescence ..............            (2,154)             (2,032)
                                              -------------        ------------
                                              $      23,757        $     25,218
                                              =============        ============

</TABLE>


                                       6

<PAGE>

3.   Subsidiaries Guaranteeing Debt and Segment Data. The Company is the 100%
owner of certain subsidiaries which do not guarantee the Company's senior
subordinated notes and certain bank debt. The following tables disclose required
consolidating financial information for guarantor, including the Company, and
non-guarantor subsidiaries (amounts in thousands):

                  HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES
                    GUARANTOR AND NON-GUARANTOR SUBSIDIARIES
                 UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEET



                                     ASSETS
<TABLE>
<CAPTION>
                                                                         As of March 31, 2002
                                                        --------------------------------------------------------
                                                                           Non-
                                                         Guarantor       Guarantor  Eliminations       Total
                                                        -----------      ---------  ------------     -----------
<S>                                                     <C>              <C>        <C>              <C>
CURRENT ASSETS:
   Cash ...........................................     $     4,084      $   2,146     $      --     $     6,230
   Accounts receivable ............................          15,688          5,711            --          21,399
   Receivables from non-guarantor .................           7,831             --        (7,831)             --
   Inventories ....................................          18,730          7,025        (1,998)         23,757
   Other current assets ...........................           2,003         11,999       (12,032)          1,970
                                                        -----------      ---------     ----------    -----------
      Total current assets ........................          48,336         26,881       (21,861)         53,356
                                                        -----------      ---------     ----------    -----------


PROPERTY, PLANT
   AND EQUIPMENT, NET .............................          44,053          1,130            --          45,183
                                                        -----------      ---------     ---------     -----------

OTHER ASSETS:
   Goodwill, net ..................................              --         29,141            --          29,141
   Deferred financing costs,  net .................           7,880             --            --           7,880
   Investment in non-guarantor subsidiaries .......          28,623             --       (28,623)             --
   Other ..........................................             802            224            --           1,026
                                                        -----------      ---------     ---------     -----------
      Total other assets ..........................          37,305         29,365       (28,623)         38,047
                                                        -----------      ---------     ---------     -----------

                                                        $   129,694      $  57,376     $ (50,484)    $   136,586
                                                        ===========      =========     =========     ===========

             LIABILITIES, MANDATORILY REDEEMABLE PREFERRED STOCK AND
                         STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT LIABILITIES:
   Notes payable to bank ............................   $     5,000      $  16,306     $      --     $    21,306
   Accounts payable .................................         9,617          1,532            --          11,149
   Payables to guarantor ............................            --          7,831        (7,831)             --
   Accrued liabilities ..............................        17,805         12,501        (9,238)         21,068
                                                        -----------      ---------     ---------     -----------
      Total current liabilities .....................        32,422         38,170       (17,069)         53,523
                                                        -----------      ---------     ---------     -----------
OTHER LIABILITIES:
   NOTE PAYABLE TO AFFILIATE ........................        14,951          2,266            --          17,217
   NOTES PAYABLE TO BANK, net of current portion ....        71,450             --            --          71,450
   SENIOR SUBORDINATED NOTES PAYABLE ................       115,000             --            --         115,000
   OTHER NON-CURRENT LIABILITIES ....................           185          1,185            --           1,370
                                                        -----------      ---------     ---------     -----------
      Total liabilities .............................       234,008         41,621       (17,069)        258,560
                                                        -----------      ---------     ---------     -----------
Mandatorily-redeemable preferred stock ..............        46,301             --            --          46,301
                                                        -----------      ---------     ---------     -----------
STOCKHOLDERS' EQUITY (DEFICIT) ......................      (150,615)        15,755       (33,415)       (168,275)
                                                        -----------      ---------     ---------     -----------
                                                        $   129,694      $  57,376     $ (50,484)    $   136,586
                                                        ===========      =========     =========     ===========
</TABLE>


                                       7

<PAGE>

                  HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES
                    GUARANTOR AND NON-GUARANTOR SUBSIDIARIES
                 UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEET

                                     ASSETS

<TABLE>
<CAPTION>

                                                                        As of December 31, 2001
                                                        --------------------------------------------------------
                                                                            Non-
                                                         Guarantor        Guarantor  Eliminations       Total
                                                        -----------      ----------  ------------    -----------
<S>                                                     <C>              <C>          <C>            <C>
CURRENT ASSETS:
   Cash ...........................................     $     4,713      $   2,372     $      --     $     7,085
   Accounts receivable ............................          13,989          5,298            --          19,287
   Receivables from non-guarantor .................           6,515             --        (6,515)             --
   Inventories ....................................          20,377          7,030        (2,189)         25,218
   Other current assets ...........................           2,976         13,553       (15,046)          1,483
                                                        -----------      ---------     ----------    -----------
      Total current assets ........................          48,570         28,253       (23,750)         53,073
                                                        -----------      ---------     ----------    -----------


PROPERTY, PLANT
   AND EQUIPMENT, NET .............................          45,125          1,143            --          46,268
                                                        -----------      ---------     ---------     -----------

OTHER ASSETS:
   Intangible assets, net .........................              --         28,498            --          28,498
   Deferred financing costs,  net .................           8,316             --            --           8,316
   Investment in non-guarantor subsidiaries .......          28,623             --       (28,623)             --
   Other ..........................................             676            224            --             900
                                                        -----------      ---------     ---------     -----------
      Total other assets ..........................          37,615         28,722       (28,623)         37,714
                                                        -----------      ---------     ----------    -----------
                                                        $   131,310      $  58,118     $ (52,373)    $   137,055
                                                        ===========      =========     =========     ===========

             LIABILITIES, MANDATORILY REDEEMABLE PREFERRED STOCK AND
                         STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT LIABILITIES:
   Notes payable to bank ..........................     $     3,750      $  16,930     $      --     $    20,680
   Accounts payable ...............................          14,069          1,182            --          15,251
   Payables to guarantor ..........................              --          6,515        (6,515)             --
   Accrued liabilities ............................          14,366         15,356       (12,420)         17,302
                                                        -----------      ---------     ---------     -----------
      Total current liabilities ...................          32,185         39,983       (18,935)         53,233
                                                        -----------      ---------     ---------     -----------
OTHER LIABILITIES:
   NOTE PAYABLE TO AFFILIATE ......................          14,951          2,266            --          17,217
   NOTES PAYABLE TO BANK, net of current portion ..          73,250             --            --          73,250
   SENIOR SUBORDINATED NOTES PAYABLE ..............         115,000             --            --         115,000
   OTHER NON-CURRENT LIABILITIES ..................             146          1,041            --           1,187
                                                        -----------      ---------     ---------     -----------
      Total liabilities ...........................         235,532         43,290       (18,935)        259,887
                                                        -----------      ---------     ---------     -----------
Mandatorily-redeemable preferred stock ............          44,989             --            --          44,989
                                                        -----------      ---------     ---------     -----------

STOCKHOLDERS' EQUITY (DEFICIT) ....................        (149,211)        14,828       (33,438)       (167,821)
                                                        ------------     ---------     ---------     -----------
                                                        $   131,310      $  58,118     $ (52,373)    $   137,055
                                                        ===========      =========     =========-    ===========
</TABLE>


                                       8

<PAGE>

                  HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES
                    GUARANTOR AND NON-GUARANTOR SUBSIDIARIES
            UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

<TABLE>
<CAPTION>

                                                                   Three Months Ended March 31, 2002
                                                        --------------------------------------------------------
                                                                           Non-
                                                         Guarantor       Guarantor   Eliminations      Total
                                                        -----------      ---------   ------------    -----------
<S>                                                     <C>              <C>         <C>             <C>
NET SALES ...........................................   $    37,863      $   8,554     $  (3,432)    $    42,985
COST OF SALES .......................................        23,711          4,722        (3,508)         24,925
                                                        -----------      ---------     ---------     -----------
   Gross Profit .....................................        14,152          3,832            76          18,060
                                                        -----------      ---------     ---------     -----------
OPERATING EXPENSES:
   Selling, distribution, general and administrative.         9,502          2,320            --          11,822
   Research and development .........................           335            262            --             597
                                                        -----------      ---------     ---------     -----------
                                                              9,837          2,582            --          12,419
                                                        -----------      ---------     ---------     -----------
   Income from operations ...........................         4,315          1,250            76           5,641
                                                        -----------      ---------     ---------     -----------
OTHER INCOME AND (EXPENSES):
   Interest expense .................................         4,458            308            --           4,766
   Other, net .......................................            76              4            17              97
                                                        -----------      ---------     ---------     -----------
                                                              4,534            312            17           4,863
                                                        -----------      ---------     ---------     -----------
   (Loss) income before provision for income taxes ..          (219)           938            59             778
                                                        -----------      ---------     ---------     -----------
PROVISION FOR INCOME TAXES ..........................            --            424            --             424
                                                        -----------      ---------     ---------     -----------


Net Loss ............................................   $      (219)     $     514     $      59     $       354
                                                        ===========      =========     =========     ===========

<CAPTION>

                                                                   Three Months Ended March 31, 2001
                                                        --------------------------------------------------------
                                                                            Non-
                                                         Guarantor       Guarantor  Eliminations       Total
                                                        -----------      ---------  ------------     -----------
<S>                                                     <C>              <C>        <C>              <C>
NET SALES ...........................................   $    35,192      $   5,976     $  (3,363)    $    37,805
COST OF SALES .......................................        27,400          3,201        (2,571)         28,030
                                                        -----------      ---------     ---------     -----------
   Gross Profit .....................................         7,792          2,775          (792)          9,775
                                                        -----------      ---------     ---------     -----------
OPERATING EXPENSES:
   Selling, distribution, general and administrative.        11,088          1,433            --          12,521
   Goodwill amortization ............................           385          1,581            --           1,966
   Research and development .........................           215            249            --             464
                                                        -----------      ---------     ---------     -----------
                                                             11,688          3,263            --          14,951
                                                        -----------      ---------     ---------     -----------
   Loss from operations .............................        (3,896)          (488)         (792)         (5,176)
                                                        -----------      ---------     ---------     -----------
OTHER INCOME AND (EXPENSES):
   Interest and other expense .......................         4,471            669            --           5,140
   Other, net .......................................           165          1,081         1,113           2,359
                                                        -----------      ---------     ---------     -----------
                                                              4,636          1,750         1,113           7,499
                                                        -----------      ---------     ---------     -----------
   Loss before provision for income taxes ...........        (8,532)        (2,238)       (1,905)        (12,675)
                                                        -----------      ---------     ---------     -----------
PROVISION FOR INCOME TAXES ..........................            --            188            --             188
                                                        -----------      ---------     ---------     -----------


Net Loss ............................................   $    (8,532)     $  (2,426)    $  (1,905)    $   (12,863)
                                                        ===========      =========     =========     ===========
</TABLE>


                                       9

<PAGE>

                  HUDSON RESPIRATORY CARE INC. AND SUBSIDIARIES
                    GUARANTOR AND NON-GUARANTOR SUBSIDIARIES
            UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

<TABLE>
<CAPTION>

                                                                            Three Months Ended March 31, 2002
                                                                         ---------------------------------------
                                                                                         Non-
                                                                         Guarantor     Guarantor        Total
                                                                         ---------     ---------     -----------
<S>                                                                      <C>           <C>           <C>
Net cash provided by operating activities .........................      $  1,734      $     828     $    2,562
Net cash used in investing activities .............................        (1,814)           (97)        (1,911)
Net cash used in financing activities .............................          (548)          (998)        (1,546)
Effect of exchange rate changes on cash ...........................            --             40             40
                                                                         --------      ---------     ----------
NET DECREASE IN CASH ..............................................          (628)          (227)          (855)
CASH, beginning of period .........................................         4,713          2,372          7,085
                                                                         --------      ---------     ----------

CASH, end of period ...............................................      $  4,085      $   2,145     $    6,230
                                                                         ========      =========     ==========
<CAPTION>

                                                                            Three Months Ended March 31, 2001
                                                                         ---------------------------------------
                                                                                         Non-
                                                                         Guarantor     Guarantor        Total
                                                                         ---------     ---------     -----------
<S>                                                                      <C>           <C>           <C>
Net cash provided by (used in) operating activities ...............      $    200      $  (3,027)    $   (2,827)
Net cash (used in) provided by investing activities ...............          (975)         1,793            818
Net cash provided by financing activities .........................           500          5,842          6,342
Effect of exchange rate changes on cash ...........................            --            729            729
                                                                         --------      ---------     ----------
NET (DECREASE) INCREASE IN CASH ...................................          (275)         5,337          5,062
CASH, beginning of period .........................................           437          3,093          3,530
                                                                         --------      ---------     ----------

CASH, end of period ...............................................      $    162      $   8,430     $    8,592
                                                                         ========      =========     ==========

</TABLE>

     The Company operates in two segments: North American operations (guarantor)
and international operations (non-guarantor).

4. Subsequent Events. As of March 31, 2002, the Company was not in compliance
with certain financial and reporting covenants under agreements governing its
Credit Facility, Bank Notes Payable and Subordinated Notes. On March 30, 2002,
the Company did not make a scheduled amortization payment on the Term Loan
Facility to its senior lenders as required under the Credit Facility and as a
result, was prevented from making a scheduled interest payment due its
Subordinated Note holders on April 15, 2002. Because the Company made the
interest payment due under the Senior Subordinated Notes within the 30-day grace
period, no event of default occurred by reason thereof. The Company is currently
in compliance with the terms and provisions of the Senior Subordinated Notes.

     As of March 31, 2002, the Company's wholly-owned Swedish subsidiary, Hudson
RCI AB, was not in compliance with certain financial covenants of the Hudson RCI
AB bank facility. The Company and Hudson RCI AB are currently in discussions
with the lender and expect to receive a waiver curing all defaults. Due to the
uncertainty of receiving this waiver from the lenders, the Company has
classified the entire Hudson RCI AB bank facility as a current liability on the
unaudited condensed consolidated balance sheet at March 31, 2002. The Credit
Facility and Senior Subordinated notes are not cross-defaulted to the Hudson RCI
AB bank facility.

     On May 14, 2002, the Company reached an agreement with its senior lenders
to amend the Credit Facility to bring the Company into compliance with all terms
and provisions of this agreement. As part of this amendment, the Company issued
$20 million in new senior term notes with warrants to the Holding's majority
stockholder, $12.0 million of which was exchanged for bank term loans previously
acquired. These notes bear interest at 12% annually with interest and principal
due upon maturity on December 31, 2004. Proceeds from the senior notes were used
to pay interest due under the Subordinated Notes, fund expenses associated with
the amendment and provide funds for ongoing working capital purposes. Under the
terms of the amendment to the Credit Facility, the lenders and the Company
agreed to (i) waive all existing events of default; (ii) extend the final
maturity of the Credit Facility to June 30, 2004; (iii) amend existing
amortization to $3.8 million in 2002, $9.3 million in 2003 and $37.0 million in
2004; and (iv) amend future financial covenants. The warrants are exercisable at
the request of the holder for 20 million shares at $1.00 per share until May 15,
2009. The Company will account for the warrants in accordance with Accounting
Principals Board Opinion no. 14, "Accounting for Convertible Debt and Debt
Issued With Stock Purchase Warrants."


                                       10

<PAGE>

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
         OF OPERATIONS

     The following discussion of Hudson Respiratory Care Inc.'s (the "Company"
or "Hudson RCI") consolidated historical results of operations and financial
condition should be read in conjunction with the consolidated financial
statements of the Company and the notes thereto included elsewhere in this Form
10-Q.

Forward-Looking Statements

     This Management's Discussion and Analysis of Financial Condition and
Results of Operations contains certain "forward-looking statements" as defined
in the Private Securities Litigation Reform Act of 1995. Such statements
relating to future events and financial performance are forward-looking
statements involving risks and uncertainties that are detailed from time to time
in the Company's Securities and Exchange Commission filings.

General

     The Company's results of operations may fluctuate significantly from
quarter to quarter as a result of a number of factors, including, among others,
the buying patterns of the Company's distributors, group purchasing
organizations ("GPOs") and other purchasers of the Company's products, forecasts
regarding the severity of the annual cold and flu season, announcements of new
product introductions by the Company or its competitors, changes in the
Company's pricing of its products and the prices offered by the Company's
competitors, rate of overhead absorption due to variability in production levels
and variability in the number of shipping days in a given quarter.

Recent Developments

     As of March 31, 2002, the Company was not in compliance with certain
financial and reporting covenants under agreements governing its Credit
Facility, Bank Notes Payable and Subordinated Notes. On March 31, 2002, the
Company did not make a scheduled amortization payment of the Term Loan Facility
to its senior lenders as required under the Credit Facility. As a result, in
early April 2002, the lenders under the Credit Facility blocked the Company from
making either the April 15, 2002 interest payment required under the Senior
Subordinated Notes or the April 15, 2002 dividend payment required under the
11-1/2% Senior Exchangeable PIK Preferred Stock due 2010.

     As of March 31, 2002, the Company's wholly-owned Swedish subsidiary, Hudson
RCI AB, was not in compliance with certain financial covenants of the Hudson RCI
AB bank facility. The Company and Hudson RCI AB are currently in discussions
with the lender and expect to receive a waiver curing all defaults (see the
"Liquidity and Capital Resources" section of this Item). Due to the uncertainty
of receiving this waiver from the lenders, the Company has classified the entire
Hudson RCI AB bank facility as a current liability on the consolidated balance
sheet. The Credit Facility and Senior Subordinated notes are not cross-defaulted
to the Hudson RCI AB bank facility.

     On May 14, 2002, the Company reached an agreement with its senior lenders
to amend and restate the Credit Facility to bring the Company into compliance
with all terms and provisions of this agreement. As part of this amendment, the
Company issued $20 million in new senior term notes with warrants to the
Holding's majority stockholder, $12.0 million of which was exchanged for bank
term loans previously acquired. These notes bear interest at 12% annually with
interest and principal due upon maturity on December 31, 2004. Proceeds from the
senior notes were used to pay interest due under the Subordinated Notes, fund
expenses associated with the amendment and provide funds for ongoing working
capital purposes. Under the terms of the amendment to the Credit Facility, the
lenders and the Company agreed to (i) waive all existing events of default; (ii)
extend the final maturity of the Credit Facility to June 30, 2004; (iii) amend
existing amortization to $3.8 million in 2002, $9.3 million in 2003 and $37.0
million in 2004; and (iv) amend future financial covenants to include only a
limitation on capital expenditures and a minimum EBITDA test. As a result of the
amendment, the Company is currently in compliance with the terms and provisions
of the Credit Facility. As of June 28, 2002 there is approximately $3.5 million
of availability on the revolving loan facility under the Credit facility.

     During 2001, the Company made the decision to close the Argyle, New York
facility and move its operations to a new facility located in Tecate, Mexico,
beginning in 2002. It is anticipated that this move will cost approximately $4.6
million, of which $0.9 million relating to severance costs were recorded in
2001.


                                       11

<PAGE>

Results of Operations

     The following tables set forth, for the periods indicated, certain income
and expense items expressed in dollars and as a percentage of the Company's net
sales.

<TABLE>
<CAPTION>
                                                        Three Month Period Ended
                                                               (unaudited)
                                                       --------------------------
                                                         March 31,       March 31,
                                                           2002            2001
                                                       ------------     ---------
<S>                                                    <C>              <C>
                                                              (in thousands)
Net sales .........................................    $     42,985     $  37,805
Cost of sales .....................................          24,925        28,030
                                                       ------------     ---------
   Gross profit ...................................          18,060         9,775
Selling expenses ..................................           5,021         4,811
Distribution expenses .............................           2,312         2,777
General and administrative expenses ...............           4,489         4,933
Amortization of goodwill ..........................              --         1,966
Research and development expenses .................             597           464
                                                       ------------     ---------
Total operating expenses ..........................          12,419        14,951
                                                       ------------     ---------
Operating income (loss)............................    $      5,641     $  (5,176)
                                                       ============     =========

                                                        Three Month Period Ended
                                                               (unaudited)
                                                        -------------------------
                                                         March 31,      March 31,
                                                           2002            2001
                                                        ----------      ---------
Net sales .........................................        100.0%          100.0%
Cost of sales .....................................         58.0            74.1
                                                        --------        --------
   Gross profit ...................................         42.0            25.8
                                                        --------        --------
Selling expenses ..................................         11.7            12.7
Distribution expenses .............................          5.4             7.3
General and administrative expenses ...............         10.5            13.0
Amortization of goodwill ..........................         --               5.2
Research and development expenses .................          1.4             1.2
                                                        --------        --------
Total operating expenses ..........................         29.0            39.5
                                                        --------        --------
Operating income ..................................         13.2%          (13.7)%
                                                        ========        ========
</TABLE>

Three Months Ended March 31, 2002 Compared to Three Months Ended March 31, 2001

     Net sales, reported net of accrued rebates, were $43.0 million in the first
quarter of 2002 as compared to $37.8 million in the first quarter of 2001,
representing an increase of $5.2 million or 13.7%. Domestic hospital sales
increased by $2.5 million or 11.3% due to increased demand at the hospital
level, primarily the result of an extremely weak influenza season in 2001.
Alternate site sales increased by $0.4 million or 6.5%, reflecting continued
market growth. International sales increased by $1.9 million or 22.3%, primarily
driven by continued growth in Europe (up $1.1 million over the first quarter of
2001) and the Pacific Rim (up $1.2 million over the first quarter of 2001). OEM
sales increased by $0.4 million due to changes in purchasing patterns from some
of its OEM customers.

     The Company's gross profit for the first quarter of 2002 was $18.1 million,
an increase of $8.3 million or 84.8% from the first quarter of 2001. As a
percentage of sales, the gross profit was 42.0% and 25.8% for the first quarter
of 2002 and 2001, respectively. This increase was primarily due to (i) 2001
sales of inventory recorded at a higher net realizable value rather than
manufacturing costs as a result of the SHERIDAN(R) acquisition, (ii) increased
shipping costs in 2001 as a result of shipping difficulties caused by problems
associated with the new management information system, and (iii) underabsorption
in 2001 of manufacturing overhead as a result of an aggressive plan to reduce
inventories by slowing production and an unfavorable mix variance caused by
higher sales of products at lower gross margins.


                                       12

<PAGE>

     Selling expenses were $5.0 million for the first quarter of 2002,
relatively unchanged from the first quarter of 2001. As a percentage of net
sales, selling expenses were 11.7% in the first quarter of 2002 as compared to
12.7% in the first quarter of 2001.

     Distribution expenses were $2.3 million for the first quarter of 2002, a
decrease of $0.5 million or 16.7% from the first quarter of 2001. This decline
is primarily the result of specific programs implemented by management designed
to improve the efficiency of its distribution facilities, including closure of
the Company's Atlanta distribution center in August 2001. As a percentage of
sales, distribution expenses decreased to 5.4% in the first quarter of 2002 as
compared to 7.3% in the first quarter of 2001.

     General and administrative expenses were $4.5 million in the first quarter
of 2002, a decrease of $0.4 million or 7.8% from the first quarter of 2001. This
decrease was primarily the result of decreased staffing levels. As a percentage
of net sales, general and administrative expenses were 10.5% in the first
quarter of 2002 as compared to 13.0% in the first quarter of 2001.

     Research and development expenses were $0.6 million for the first quarter
of 2002, relatively unchanged from the expense of $0.5 million incurred in the
first quarter 2001.

     Amortization of goodwill was $0.0 million in the first quarter for 2002, as
compared to $2.0 million in the first quarter of 2001. This is the result of the
adoption of SFAS 142, under which the Company ceased amortizing goodwill
effective January 1, 2002.

     Interest expense was $4.8 million for the first quarter of 2002, as
compared to $5.1 million in the first quarter of 2001. The decrease was due to
lower interest rates.

Liquidity and Capital Resources

The Company's primary sources of liquidity are cash flow from operations,
borrowings under its working capital bank facility and historically, investments
from shareholders. Cash provided by (used in) operations totaled $2.6 million
and $(2.8) million in the first quarter of 2002 and 2001, respectively. The
increase in the first quarter of 2002 as compared to the first quarter of 2001
is primarily attributable to increased operating income and an increase in
accrued liabilities partially offset by a decrease in payables and an increases
in accounts receivable. The Company had operating working capital deficit of
$(0.3) million and $(0.2) million as of the end of the first quarter of 2002 and
2001, respectively. Inventories were $23.7 million and $25.2 million as of the
end of the first quarter of 2002 and December 31, 2001, respectively. In order
to meet the needs of its customers, the Company must maintain inventories
sufficient to permit same-day or next-day filling of most orders. Such
inventories are higher than those that would be required for delayed filling of
orders, thus adversely impacting liquidity. Over time, the Company expects its
level of inventories to increase, as the Company's international sales increase.
Accounts receivable, net of allowances, were $21.4 million and $19.3 million at
March 31, 2002 and December 31, 2001, respectively. The Company typically offers
30-day credit terms to its U.S. hospital distributors. Alternate site and
international customers typically receive 60 to 90 day terms and, as a result,
as the Company's alternate site and international sales have increased, the
amount and aging of its accounts receivable have increased. The Company
anticipates that the amount and aging of its accounts receivable will continue
to increase as the alternate site and international markets become a larger
percentage of the Company's overall sales.

     During the three months ended March 31, 2002, net cash used investing
activities was $1.9 million, reflecting primarily purchases of manufacturing
equipment and new heater placements. During the three months ended March 31,
2001, net cash used in investing activities was $0.9 million, primarily
reflecting purchases of manufacturing equipment. The Company currently estimates
that capital expenditures will be approximately $8.0 million in each of 2002 and
2003, consisting primarily of additional and replacement manufacturing equipment
and new heater placements.

     During the three months ended March 31, 2002 and March 31, 2001, net cash
(used in) provided by financing was $(1.5) million and $6.2 million,
respectively, reflecting repayment of the Company's borrowings in the first
quarter of 2002 and borrowings made through Hudson RCI AB, the Company's Swedish
subsidiary in the first quarter of 2001.


                                       13

<PAGE>

     As of March 31, 2002, The Company had outstanding $225.0 million of
indebtedness, consisting of $115.0 million of Subordinated Notes, borrowings of
$76.5 million under the Company's Credit Facility, $17.2 million in notes
payable to affiliates and $16.3 million in outstanding borrowings under the bank
facility of Hudson RCI AB.

     The Credit Facility currently consists of a $40.0 million Term Loan
Facility and a $55.0 million Revolving Loan Facility of which up to $40.0
million (all of which has been borrowed and is outstanding) may be used for
permitted acquisitions ("Acquisition Facility") and up to $15 million (the
"Working Capital Portion") may be used for general corporate purposes (other
than acquisitions). The Revolving Loan Facility has a letter of credit sub-limit
of $7.5 million. The Term Loan Facility and Acquisition Facility, as amended,
matures on June 30, 2004 and requires quarterly principal installments totaling
$3.8 million in 2002, $9.3 million in 2003 and $37.0 million in 2004. The
Revolving Loan Facility matures on June 30, 2004.

     Total borrowings as of March 31, 2002 was $54.5 million under the Revolving
Loan Facility and $22.0 million under the Term Loan Facility.

     The interest rate under the Credit Facility is based, at the option of the
Company, upon either a Eurodollar rate or a base rate (as defined), plus a
margin during the period and for the type of loan as follows:

<TABLE>
<CAPTION>
                                                           Margin
                                                    ------------------------
Period and Loan Type                                Base Rate     Eurodollar
--------------------                                ---------     ----------
<S>                                                 <C>           <C>
Through June, 2002
  Term and Working Capital                               3.00%          4.00%
  Acquisition                                            3.25%          4.25%

July, 2002 through March, 2003
  Term and Working Capital                               3.50%          4.50%
  Acquisition                                            3.75%          4.75%

Thereafter
  Term and Working Capital                               4.00%          5.00%
  Acquisition                                            4.25%          5.25%
</TABLE>

     For periods after June 2002, the margins set forth above are subject to
pricing reductions depending on the Company's then existing leverage ratio.

         Borrowings under the Credit Facility are required to be prepaid,
subject to certain exceptions, with (i) 75% (or 50% for years when the Company's
ratio of Debt to EBITDA (as defined) is less than 5:1) of Excess Cash Flow (as
defined), (ii) 50% of the net cash proceeds of an equity issuance by River
Holding Corp., the Company's parent ("Holding") or the Company in connection
with an initial public offering or 100% of the net cash proceeds of an equity
issuance by Holding. Holding or the Company other than in connection with an
initial public offering (subject in each case to certain exceptions), (iii) 100%
of the net cash proceeds of the sale or other disposition of any properties or
assets of Holding and its subsidiaries (subject to certain exceptions), (iv)
100% of the net proceeds of certain issuances of debt obligations of the Company
and its subsidiaries and (v) 100% of the net proceeds from insurance recoveries
and condemnations. The Revolving Loan Facility must be repaid upon payment in
full of the Term Loan Facility.

     The Credit Facility is guaranteed by Holding and certain of the Company's
subsidiaries. The Credit Facility is secured by a first priority lien in
substantially all of the properties and assets of the Company and the guarantors
now owned or acquired later, including a pledge of all of the capital stock of
the Company owned by Holding and all of the shares held by the Company of its
existing and future subsidiaries; provided, that such pledge is limited to 65%
of the shares of any foreign subsidiary to the extent a pledge of a greater
percentage would result in adverse tax consequences to the Company.


                                       14

<PAGE>

     The Credit Facility contains covenants restricting the ability of Holding,
the Company and the Company's subsidiaries to, among other things, (i) incur
additional debt, (ii) declare dividends or redeem or repurchase capital stock,
(iii) prepay, redeem or purchase debt, (iv) incur liens, (v) make loans and
investments, (vi) make capital expenditures, (vii) engage in mergers,
acquisitions and asset sales, and (viii) engage in transactions with affiliates.
Hudson RCI is also required to comply with financial covenants with respect to
(a) limits on annual aggregate capital expenditures (as defined) and (b), a
minimum EBITDA test.

     The Subordinated Notes bear interest at the rate of 9-1/8%, payable
semiannually on each April 15 and October 15, and will require no principal
repayments until maturity. The Subordinated Notes are general unsecured
obligations of the Company. The Subordinated Notes contain covenants that place
limitations on, among other things, (i) the ability of the Company, any
subsidiary guarantors and other restricted subsidiaries to incur additional
debt, (ii) the making of certain restricted payments including investments,
(iii) the creation of certain liens, (iv) the issuance and sale of capital stock
of restricted subsidiaries, (v) asset sales, (vi) payment restrictions affecting
restricted subsidiaries, (vii) transactions with affiliates and (viii) the
ability of the Company and any subsidiary guarantor to incur layered debt, (ix)
the ability of Holding to engage in any business or activity other than those
relating to ownership of capital stock of the Company and (x) certain mergers,
consolidations and transfers of assets by or involving the Company. The Company
was prevented from making the April 15, 2002 interest payment to holders of the
Senior Subordinated Notes pending the completion of the amendment to the Credit
facility on May 14, 2002. Because the Company made the interest payment due
under the Senior Subordinated Notes within the 30-day grace period, no event of
default occurred by reason thereof. The Company is currently in compliance with
the terms and provisions of the Senior Subordinated Notes.

     As of March 31, 2002, the Company had $13.2 million outstanding pursuant to
unsecured promissory notes payable to affiliates of Freeman Spogli, the
Holding's majority stockholder. The notes bear interest at 10.0% per annum and
mature in March 2005. Interest may be paid or deferred to the due date at the
option of the Company and the notes are convertible to the Company's common
stock at the demand of the holder. The notes are subordinated to borrowings
under the Credit facility and rank pari-passu with the Senior Subordinated
Notes.

     The Company, through Hudson RCI AB, has incurred bank debt in Sweden (the
"HRCI AB Facility") that totaled $16.3 million as of March 31, 2002. The HRCI AB
Facility, which is denominated in Swedish krona, bears interest at three-month
STIBOR plus 1.25% to 1.85% (5.14% to 5.74% at March 31, 2002), matures in
December 2003, and is guaranteed by Steamer Holding AB, Hudson RCI AB's parent,
and is secured by the common stock of Hudson RCI AB. As of March 31, 2002,
Hudson RCI AB was not in compliance with certain financial covenants under the
Hudson RCI AB facility. The Company and Hudson RCI AB are currently in
negotiations with the lender concerning an amendment curing these defaults and
expects to receive from the lender a waiver curing all past covenant violations,
but no assurance can be given that such an agreement will be reached.
Accordingly, the entire outstanding balance of the Hudson RCI AB Facility is
classified as current on the consolidated balance sheet. The Company's Credit
Facility and the Senior Subordinated Notes are not cross-defaulted to the Hudson
RCI AB facility. If a waiver of such default is not obtained, the lender may
pursue its remedies under the facility, including, among other things, immediate
acceleration of all borrowings of the facility. In addition, the default
entitles the lender to take control of all the common stock of Hudson RCI AB and
its European parent companies.

     The Company has issued to Holding 300,000 shares of its 11-1/2% Senior
Exchangeable PIK Preferred Stock due 2010 with an aggregate liquidation
preference of $30.0 million, which has terms and provisions materially similar
to those of the 11 1/2% Senior Exchangeable PIK Preferred Stock due 2010 issued
by Holding. At the election of the Company, dividends may be paid in kind until
April 15, 2003 and thereafter must be paid in cash.

     In August 2001, the Company issued 3,000 shares of 12% Junior Convertible
Cumulative Preferred Stock (the "Junior Preferred Stock") to Holding, for total
cash consideration to the Company of $3.0 million. Each share of the Junior
Preferred Stock may be redeemed, from time to time, in whole or in part, at the
option of the Company at a redemption price of 100% of the Liquidation
Preference of the Junior Preferred Stock or $1,000 per share plus accumulated
and unpaid dividends that would be payable on such shares of Junior Preferred
Stock.

     The Company was not in compliance with certain financial covenants of the
Credit Facility as of December 31, 2001 and did not make the scheduled March 31,
2002 amortization payment of the Term Loan Facility on its due date. As


                                       15

<PAGE>

a result, in early April, 2002, the lenders under the Credit Facility blocked
the Company from making either the April 15, 2002 interest payment required
under the Senior Subordinated Notes or the April 15, 2002 dividend payment
required under the 11-1/2% Senior Exchangeable PIK Preferred Stock due 2010. On
May 14, 2002, the Company and banks amended and restated the Credit Facility to
(i) waive all existing events of default; (ii) extend the final maturity of the
term and revolving facilities under the Credit Facility to June 30, 2004; (iii)
amend existing Term Loan and Acquisition Facility amortization to $3.8 million
in 2002, $9.3 million in 2003 and $37.0 million in 2004, and (iv) amend the
financial covenants to include only a limitation on capital expenditures and a
minimum EBITDA test. As a result of the amendment, the Company is currently in
compliance with the terms and provisions of the Credit Facility. As of May 31,
2002, there was approximately $3.5 million of availability on the revolving Loan
Facility under the Credit Facility.

     As part of the May 2002 amendment and restatement of the Credit Facility
discussed above, the Company issued $12.0 million of the senior unsecured notes
in exchange for $12.0 million of bank term loans purchased a wholly-owned
subsidiary of the Company by affiliates of Holding's majority stockholder.
Additionally, HRC Holding issued $8.0 million of unsecured senior notes to
affiliates of Holding's majority stockholder. HRC Holding used the proceeds of
the notes issued by it to acquire certain intercompany receivables from the
Company. These notes bear interest at 12% annually with interest and principal
due upon maturity on December 31, 2004. Proceeds from these transactions were
used to pay the April 2002 interest due under the Subordinated Notes, fund
expenses associated with the Amended and Restated Credit Facility and provide
funds for ongoing general corporate purposes

     Also in May 2002, the Company issued warrants to purchase 20.0 million
shares of the Company's common stock.

Recent Accounting Pronouncements

     Effective January 1, 2001, the Company adopted Statement of Financial
Accounting Standards No.133, "Accounting for Derivative Instruments and Hedging
Activities," as amended by SFAS No. 137 and SFAS No. 138. SFAS No. 133, as
amended, establishes accounting and reporting standards for derivative
instruments. The statement requires that every derivative instrument be recorded
in the balance sheet as either an asset or liability measured at its fair value,
and that changes in the derivative's fair value be recognized currently in
earnings unless specific hedge accounting criteria are met. The adoption of this
new standard did not have a material impact on the Company's financial
statements.

     In June 2001, the Financial Accounting Standards Board ("FASB") issued
Statement of Financial Accounting Standards No. 141, "Business Combinations"
("SFAS 141"). This Statement addresses financial accounting and reporting for
business combinations and supersedes APB Opinion No. 16, "Business
Combinations," and FASB Statement No. 38, "Accounting for Preacquisition
Contingencies of Purchased Enterprises." All business combinations in the scope
of this Statement are to be accounted for using one method, the purchase method.
Any acquisitions made by the Company after June 2001 will be recorded in
accordance with SFAS 141.

     Also in June 2001, the FASB issued Statement of Financial Accounting
Standards No. 142, "Goodwill and Other Intangible Assets" ("SFAS 142"). SFAS 142
addresses financial accounting and reporting for acquired goodwill and other
intangible assets and supersedes APB Opinion No. 17, "Intangible Assets." This
pronouncement addresses, among other things, how goodwill and other intangible
assets should be accounted for after they have been initially recognized in the
financial statements. Goodwill will no longer be amortized but will be assessed
at least annually for impairment using a fair value methodology. The Company
stopped amortizing goodwill, effective January 1, 2002, an as a result an
equivalent charge for goodwill amortization will not be made in 2002. The
Company is still evaluating the impact of the standard on impairment, which is
expected to be completed by the end of the second quarter of 2002.

     Also in June 2001, the FASB issued SFAS No. 143, "Accounting for Asset
Retirement Obligations" ("SFAS 143"). SFAS 143 addresses financial accounting
and reporting obligations associated with the retirement of tangible long-lived
assets and the associated asset retirement costs. It requires entities to record
the fair value of a liability for an asset retirement obligation in the period
in which it is incurred. When the liability is initially recorded, the entity
capitalizes a cost by increasing the carrying amount of the related long-lived
asset. Over time, the liability is acreted to its present value each period, and
the capitalized cost is depreciated over the useful live of the related asset.
Upon settlement of the liability, an entity either settles the obligation for
its recorded amount or incurs gain or loss upon


                                       16

<PAGE>

settlement. SFAS 143 is effective January 1, 2003. The Company does not expect
the adoption of SFAS 143 to have a material impact on the Company's financial
statements.

     In August 2001, the FASB issued SFAS 144 "Accounting for the Impairment or
Disposal of Long-Lived Assets." This statement addresses financial accounting
and reporting for the impairment or disposal of long-lived assets. This
statement supercedes SFAS No. 121, "Accounting for the Impairment of Long-Lived
Assets and for Long-Lived Assets to be Disposed Of," and the accounting and
reporting provisions of APB Opinion No. 30, "Reporting the Results of Operations
- Reporting the Effects of a Disposal of a Segment of a Business and
Extraordinary, Unusual and Infrequently Occurring Events and Transactions," for
the disposal of a segment of a business (as previously defined in that Opinion).
SFAS No. 144 was effective January 1, 2002. The adoption of SFAS 144 did not
have a material impact on the Company's financial statements.


                                       17

<PAGE>

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS

     There have been no material changes in the Company's market risk exposure
from that reported in the Company's 10-K for the fiscal year ended December 31,
2001.


                                       18

<PAGE>

                           PART II. OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

     None.

ITEM 2.  CHANGES IN SECURITIES

     Not applicable.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

     Not applicable.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

     None.

ITEM 5.  OTHER INFORMATION

     None.

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

     (a)  Exhibits

          10.1(1)  Amended and restated Credit Agreement dated as of May 14,
                   2002 among Hudson RCI, Holding, the Lenders party thereto,
                   and Deutsche bank Trust Americas ("Deutsche Bank"),
                   as administrative agent and collateral agent
          10.2(1)  Form of Amended and Restated Security Agreement dated as of
                   May 14, 2002 between Hudson RCI and Deutsche Bank.
          10.13(1) Form of Nonrecourse Pledge Agreement dated as of May 14,
                   2002 among the Pledgor and Deutsche Bank, as collateral agent
                   for the Lenders.
          10.15(1) Tecate Facility Sub-Lease
          10.16(1) Form of Supplement No. 1 dated as of May 14, 2002, to the
                   Pledge Agreement.
          10.17(1) Form of Master Assignment and Exchange Agreement dated as of
                   May 14, 2002 by and among Holding, Hudson RCI, the financial
                   institutions listed on the signature pages thereof, Deutsche
                   Bank, as administrative agent for the Lenders and FSEP IV.
          10.18(1) Letter agreement dated August 17, 2001 between Hudson RCI
                   and Charles French.
          10.19(1) Form of Stock Option Plan
          10.20(1) Form of Stock Option Agreement
          10.21(1) Receivables Purchase Agreement dated May 14, 2002 by and
                   between Hudson RCI and HRC Holding.

     (b)  Reports on Form 8-K

          None.

----------------------------

              (1)  Incorporated by reference to the exhibit designated by the
                   same number in the Form 10-K filed by the Company for the
                   fiscal year ended December 31, 2001.


                                       19

<PAGE>

                                    SIGNATURE

     Pursuant to the requirements of the Securities Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.

                                 HUDSON RESPIRATORY CARE INC.,
                                 a California corporation

June 28, 2002                    By:  /s/ Patrick G. Yount
                                      -----------------------------------------
                                      Patrick G. Yount
                                      Chief Financial Officer
                                      (Duly Authorized Officer and Principal
                                      Financial Officer)

                                       20